Chinese oral anti-COVID drug delivered to epidemic-hit regions, ‘effective’ in inhibiting virus
China-developed oral drug for COVID-19 treatment Azvudine has been delivered to various epidemic-hit regions, including Central China’s Henan, South China’s Hainan, and Northwest China’s Xinjiang region, according to the company.…